Key Insights
The Brazilian contraceptive devices market, valued at approximately $XX million in 2025 (estimated based on provided CAGR and market trends), is projected to experience robust growth, with a Compound Annual Growth Rate (CAGR) of 6.70% from 2025 to 2033. This expansion is driven by several factors, including increasing awareness of family planning and reproductive health, rising female participation in the workforce, and government initiatives promoting access to contraception. The market is segmented by type (condoms, diaphragms, IUDs, etc.) and gender, reflecting the diverse needs of the Brazilian population. Condoms and IUDs are likely to dominate market share, given their widespread availability and affordability. However, growth in other segments, such as vaginal rings and hormonal implants, is anticipated due to increased demand for longer-acting and more discreet options. While challenges remain, such as socioeconomic disparities in access and persistent cultural barriers in some regions, the overall market outlook is positive, indicating significant opportunities for established players and new entrants alike.
The market's growth trajectory is influenced by evolving trends, such as a shift towards convenient and long-acting reversible contraceptives (LARCs), increased online sales of contraceptives, and growing demand for comprehensive sexual and reproductive healthcare services. However, restraining factors include the cost of certain contraceptive devices, limited access to healthcare in remote areas, and ongoing misinformation campaigns that hinder contraceptive adoption. Key players, including AbbVie Inc, Ansell Ltd, Bayer AG, and Johnson & Johnson, are likely to leverage technological advancements, strategic partnerships, and targeted marketing campaigns to maintain their market positions and capitalize on growth prospects. The increasing focus on telehealth and digital health solutions may also contribute significantly to market expansion in the coming years, by enhancing access to information and services in underserved communities.

Brazil Contraceptive Devices Industry: A Comprehensive Market Report (2019-2033)
This dynamic report provides a detailed analysis of the Brazil contraceptive devices market, offering invaluable insights for industry stakeholders, investors, and researchers. Leveraging extensive data from 2019-2024 (historical period), the report projects market trends through 2033, with a base year of 2025 and a forecast period of 2025-2033. The report covers market size, segmentation, competitive landscape, key players, and future outlook, providing a comprehensive understanding of this vital market.
Brazil Contraceptive Devices Industry Market Structure & Competitive Landscape
The Brazilian contraceptive devices market exhibits a moderately concentrated structure, with a few multinational corporations holding significant market share. Concentration ratios (e.g., CR4) are estimated at xx%, indicating a balance between larger players and smaller niche companies. Innovation is driven by the need for improved efficacy, safety, and user experience. The regulatory landscape, governed primarily by Anvisa (National Health Surveillance Agency), plays a crucial role in shaping market access and product development. Product substitutes, such as natural family planning methods, exist but pose limited competition to established contraceptive devices. The end-user segment is primarily composed of women of reproductive age, with varying needs and preferences across socioeconomic groups. Mergers and acquisitions (M&A) activity in the Brazilian contraceptive devices market has been moderate, with xx M&A deals recorded between 2019 and 2024, primarily focused on expanding product portfolios and market reach.
- Key Market Characteristics: Moderately concentrated, innovation-driven, regulated environment, limited product substitution.
- End-User Segmentation: Primarily women of reproductive age, diverse socioeconomic backgrounds.
- M&A Activity: Moderate activity (xx deals, 2019-2024), focused on portfolio expansion and market access.
Brazil Contraceptive Devices Industry Market Trends & Opportunities
The Brazilian contraceptive devices market is projected to experience significant growth during the forecast period (2025-2033). Market size is estimated at USD xx Million in 2025 and is projected to reach USD xx Million by 2033, representing a Compound Annual Growth Rate (CAGR) of xx%. This growth is fueled by several factors, including increasing awareness of family planning, government initiatives promoting access to contraceptives, and the rising prevalence of sexually transmitted infections (STIs). Technological advancements, such as the development of long-acting reversible contraceptives (LARCs) like IUDs, are further driving market expansion. However, challenges such as limited access to healthcare in certain regions, socio-cultural barriers, and affordability concerns persist and could potentially restrain market growth. The increasing demand for user-friendly and discreet contraceptive options presents significant opportunities for innovative product development and market penetration. The market penetration rate for contraceptives in Brazil is currently estimated at xx%, with substantial room for growth, especially in underserved populations. Competitive dynamics are characterized by intense rivalry among established players, along with the emergence of new entrants offering innovative product offerings.

Dominant Markets & Segments in Brazil Contraceptive Devices Industry
The Brazilian contraceptive devices market is geographically diverse, with varying levels of demand and market penetration across different regions. However, urban centers tend to exhibit higher consumption rates due to improved access to healthcare services. By type, condoms remain the most dominant segment, driven by affordability and accessibility. However, the IUD segment is witnessing rapid growth due to its long-acting and highly effective nature. The female segment accounts for the majority of market demand, although the male contraceptive segment is also experiencing modest growth.
- Growth Drivers (IUD Segment):
- Government initiatives promoting IUD placement (e.g., USD 95 Million investment in 2022).
- Increasing awareness of IUD benefits (long-acting, highly effective).
- Improved access to healthcare services.
- Dominant Segments: Condoms (by type), Female (by gender).
- High-Growth Segments: IUDs (by type).
Brazil Contraceptive Devices Industry Product Analysis
The Brazilian contraceptive devices market encompasses a wide array of products, including condoms, oral contraceptives, IUDs, implants, and emergency contraception. Technological advancements have led to the development of more effective, safer, and user-friendly contraceptives, such as long-acting reversible contraceptives (LARCs). These innovations address consumer needs for convenient, discreet, and long-term contraception options. Competitive advantages are determined by factors like efficacy, safety profile, pricing, and marketing strategies. The market is witnessing a shift towards preference for long-acting reversible contraception methods, highlighting the success of technological advancements in fulfilling specific unmet needs.
Key Drivers, Barriers & Challenges in Brazil Contraceptive Devices Industry
Key Drivers: Increased awareness of family planning, government initiatives promoting access to contraceptives, rising prevalence of STIs, technological advancements (LARCs), and growing female economic empowerment.
Challenges: Limited access to healthcare in certain regions, socio-cultural barriers, affordability concerns, stringent regulatory requirements, and fluctuations in raw material prices that impact supply chain stability. These factors constrain overall market expansion and accessibility.
Growth Drivers in the Brazil Contraceptive Devices Industry Market
Growth in the Brazilian contraceptive devices market is driven by increasing awareness of family planning, rising prevalence of STIs, supportive government policies such as increased funding for IUD placements, and technological advancements in contraceptive methods. Economic factors, including rising disposable incomes in some segments of the population, are also positively impacting market growth.
Challenges Impacting Brazil Contraceptive Devices Industry Growth
Challenges include limited access to healthcare in rural areas, sociocultural barriers hindering adoption of modern contraceptives, affordability constraints for many consumers, and regulatory complexities impacting product approval and market entry. Supply chain disruptions and competition from cheaper, less regulated alternatives also impede market expansion.
Key Players Shaping the Brazil Contraceptive Devices Industry Market
- AbbVie Inc (Allergan PLC)
- Ansell Ltd
- Veru Inc (The Female Health Company)
- Bayer AG
- Reckitt Benckiser Group plc
- Johnson & Johnson
- Merck & Co
- Church & Dwight Co Inc
- The Cooper Companies Inc
- Pfizer Inc
Significant Brazil Contraceptive Devices Industry Milestones
- August 2022: Anvisa approves a new contraceptive pill (Nextela) with a safer formulation, expected to launch in 2023-2024. This signifies a positive shift towards safer and more effective contraceptive options, boosting market confidence and consumer uptake.
- June 2022: The Ministry of Health invests USD 95 Million in 31,600 IUD placement procedures. This substantial investment significantly increases access to long-acting, highly effective contraception, stimulating market growth in this segment.
Future Outlook for Brazil Contraceptive Devices Industry Market
The Brazilian contraceptive devices market is poised for continued growth, driven by increasing awareness, government support, and technological advancements. Strategic opportunities lie in expanding access to contraceptives in underserved populations, focusing on innovative product development, and strengthening partnerships with healthcare providers. The market's future potential is significant, particularly in leveraging digital channels for awareness and education campaigns. Continued investment in research and development of safer and more effective contraceptive technologies will be crucial for long-term market expansion.
Brazil Contraceptive Devices Industry Segmentation
-
1. Type
- 1.1. Condoms
- 1.2. Diaphragms
- 1.3. Cervical Caps
- 1.4. Sponges
- 1.5. Vaginal Rings
- 1.6. Intra Uterine Device (IUD)
- 1.7. Other Devices
-
2. Gender
- 2.1. Male
- 2.2. Female
Brazil Contraceptive Devices Industry Segmentation By Geography
- 1. Brazil

Brazil Contraceptive Devices Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.70% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Incidence of Sexually Transmitted Diseases (STDs); Increase in Unplanned Pregnancies
- 3.3. Market Restrains
- 3.3.1. Side Effects Associated with the Use of Contraceptive Devices
- 3.4. Market Trends
- 3.4.1. Condoms Segment is Expected to Witness a Significant Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Brazil Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Condoms
- 5.1.2. Diaphragms
- 5.1.3. Cervical Caps
- 5.1.4. Sponges
- 5.1.5. Vaginal Rings
- 5.1.6. Intra Uterine Device (IUD)
- 5.1.7. Other Devices
- 5.2. Market Analysis, Insights and Forecast - by Gender
- 5.2.1. Male
- 5.2.2. Female
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Brazil
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 AbbVie Inc (Allergan PLC)
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Ansell Ltd
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Veru Inc (The Female Health Company)
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Bayer AG
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Reckitt Benckiser Group plc
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Johnson & Johnson
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Merck & Co *List Not Exhaustive
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Church & Dwight Co Inc
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 The Cooper Companies Inc
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Pfizer Inc
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 AbbVie Inc (Allergan PLC)
List of Figures
- Figure 1: Brazil Contraceptive Devices Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Brazil Contraceptive Devices Industry Share (%) by Company 2024
List of Tables
- Table 1: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 3: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 4: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 7: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 8: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Brazil Contraceptive Devices Industry?
The projected CAGR is approximately 6.70%.
2. Which companies are prominent players in the Brazil Contraceptive Devices Industry?
Key companies in the market include AbbVie Inc (Allergan PLC), Ansell Ltd, Veru Inc (The Female Health Company), Bayer AG, Reckitt Benckiser Group plc, Johnson & Johnson, Merck & Co *List Not Exhaustive, Church & Dwight Co Inc, The Cooper Companies Inc, Pfizer Inc.
3. What are the main segments of the Brazil Contraceptive Devices Industry?
The market segments include Type, Gender.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Incidence of Sexually Transmitted Diseases (STDs); Increase in Unplanned Pregnancies.
6. What are the notable trends driving market growth?
Condoms Segment is Expected to Witness a Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Side Effects Associated with the Use of Contraceptive Devices.
8. Can you provide examples of recent developments in the market?
August 2022: The National Health Surveillance Agency (Anvisa) approved a new contraceptive pill whose formulation is meant to be less harmful to women's bodies and lower the risk of thrombosis. According to the Libbs (Manufacturer), it is anticipated to arrive on store shelves in Brazil between 2023 and 2024 under the brand Nextela.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Brazil Contraceptive Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Brazil Contraceptive Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Brazil Contraceptive Devices Industry?
To stay informed about further developments, trends, and reports in the Brazil Contraceptive Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence